155 related articles for article (PubMed ID: 1346799)
1. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 Mar; 10(3):352-5. PubMed ID: 1346799
[No Abstract] [Full Text] [Related]
2. The purine analogs--a therapeutic beauty contest.
Cheson BD
J Clin Oncol; 1992 May; 10(5):868-71. PubMed ID: 1349035
[No Abstract] [Full Text] [Related]
3. Pentostatin and 2-chlorodeoxyadenosine for hairy-cell leukemia.
Med Lett Drugs Ther; 1992 Sep; 34(879):89-90. PubMed ID: 1355592
[No Abstract] [Full Text] [Related]
4. New purine analogues for the treatment of chronic B-cell malignancies.
Gribbin TE
Henry Ford Hosp Med J; 1991; 39(2):98-102. PubMed ID: 1679757
[TBL] [Abstract][Full Text] [Related]
5. Purine analogs in lymphoproliferative disorders.
Cheson BD
Leuk Lymphoma; 1993; 11 Suppl 2():153-9. PubMed ID: 7907252
[No Abstract] [Full Text] [Related]
6. 2-Chlorodeoxyadenosine treatment of lymphoid malignancies.
Piro LD
Blood; 1992 Feb; 79(4):843-5. PubMed ID: 1346575
[No Abstract] [Full Text] [Related]
7. [New analogs of deoxyadenosine for treatment of lymphoid malignancies].
Robak T
Przegl Lek; 1992; 49(10):355-8. PubMed ID: 1364050
[No Abstract] [Full Text] [Related]
8. Purine analogs in leukemia.
Lamanna N; Weiss M
Adv Pharmacol; 2004; 51():107-25. PubMed ID: 15464907
[No Abstract] [Full Text] [Related]
9. Purine analogues for treatment of refractory essential mixed cryoglobulinemia.
Enzenauer RJ; Judson PH
Mayo Clin Proc; 1997 Jan; 72(1):92-3. PubMed ID: 9005296
[No Abstract] [Full Text] [Related]
10. The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.
Saven A; Piro LD
Cancer; 1993 Dec; 72(11 Suppl):3470-83. PubMed ID: 7902205
[TBL] [Abstract][Full Text] [Related]
11. The treatment of hairy cell leukemia: an update.
Golomb HM; Ratain MJ; Mick R; Daly K
Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
[TBL] [Abstract][Full Text] [Related]
12. Hairy cell leukemia. What is new forty years after the first description?
Troussard X; Maloisel F; Flandrin G
Hematol Cell Ther; 1998 Aug; 40(4):139-48. PubMed ID: 9766918
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on purine analogues.
Cheson BD
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S109-16. PubMed ID: 9137964
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials referral resource. Clinical trials with 2-chlorodeoxyadenosine.
Cheson BD
Oncology (Williston Park); 1992 May; 6(5):95-8. PubMed ID: 1350917
[No Abstract] [Full Text] [Related]
15. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
[No Abstract] [Full Text] [Related]
16. Lymphoma, hairy-cell leukemia respond to new agents.
Oncology (Williston Park); 1992 Sep; 6(9):94. PubMed ID: 1449980
[No Abstract] [Full Text] [Related]
17. Comparative efficacy of the newer nucleosides (fludarabine, 2'-deoxycoformycin, and 2-chlorodeoxyadenosine) in the treatment of indolent lymphoid malignancies.
Saven A
Semin Hematol; 1993 Oct; 30(4 Suppl 6):31-3. PubMed ID: 7908757
[No Abstract] [Full Text] [Related]
18. 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.
Kay AC; Saven A; Carrera CJ; Carson DA; Thurston D; Beutler E; Piro LD
J Clin Oncol; 1992 Mar; 10(3):371-7. PubMed ID: 1346801
[TBL] [Abstract][Full Text] [Related]
19. Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias.
Pott-Hoeck C; Hiddemann W
Ann Oncol; 1995 May; 6(5):421-33. PubMed ID: 7669706
[TBL] [Abstract][Full Text] [Related]
20. Ennui or not ennui, that is the question..
Cheson BD
Ann Oncol; 1996 Oct; 7(8):767-9. PubMed ID: 8922188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
